Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids

1985 • 580 citations

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia

1994 • 575 citations

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

1998 • 487 citations

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2

1987 • 429 citations

Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1

2000 • 420 citations

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

1995 • 387 citations

The Inhibitory Receptor LIR-1 Uses a Common Binding Interaction to Recognize Class I MHC Molecules and the Viral Homolog UL18

1999 • 357 citations

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

2002 • 259 citations

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

2000 • 259 citations

Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

1992 • 246 citations

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

2003 • 227 citations

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation

2003 • 219 citations

The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1999 • 188 citations

Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.

1997 • 172 citations

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

2001 • 168 citations

Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans

2002 • 153 citations

Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development

1998 • 135 citations

A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

2000 • 127 citations

Two distinct HLA-A0201–presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

2002 • 110 citations

Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes.

1996 • 87 citations

Wilms' Tumor Gene Expression in Human CD34+ Hematopoietic Progenitors During Fetal Development and Early Clonogenic Growth

1997 • 67 citations

WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia

1999 • 58 citations

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes

2002 • 17 citations